Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome.

Conrad Russell Y. Cruz, Kenneth P. Micklethwaite, Barbara Savoldo, Carlos A. Ramos, Sharon Lam, Stephanie Ku, Oumar Diouf, Enli Liu, A. John Barrett, Sawa Ito, Elizabeth J. Shpall, Robert A. Krance, Rammurti T. Kamble, George Carrum, Chitra M. Hosing, Adrian P. Gee, Zhuyong Mei, Bambi J. Grilley, Helen E. Heslop, Cliona M. Rooney, Malcolm K. Brenner, Catherine M. Bollard, Gianpietro Dotti, Infusion of donor-derived CD19-redirected virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase 1 study Blood. ,vol. 122, pp. 2965- 2973 ,(2013) , 10.1182/BLOOD-2013-06-506741

Bruce D. Cheson, Richard I. Fisher, Sally F. Barrington, Franco Cavalli, Lawrence H. Schwartz, Emanuele Zucca, T. Andrew Lister, Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification Journal of Clinical Oncology. ,vol. 32, pp. 3059- 3067 ,(2014) , 10.1200/JCO.2013.54.8800

Apostolia-Maria Tsimberidou, Susan O'Brien, Issa Khouri, Francis J. Giles, Hagop M. Kantarjian, Richard Champlin, Sijin Wen, Kim-Anh Do, Susan C. Smith, Susan Lerner, Emil J. Freireich, Michael J. Keating., Clinical Outcomes and Prognostic Factors in Patients With Richter's Syndrome Treated With Chemotherapy or Chemoimmunotherapy With or Without Stem-Cell Transplantation Journal of Clinical Oncology. ,vol. 24, pp. 2343- 2351 ,(2006) , 10.1200/JCO.2005.05.0187

James N. Kochenderfer, Mark E. Dudley, Sadik H. Kassim, Robert P.T. Somerville, Robert O. Carpenter, Maryalice Stetler-Stevenson, James C. Yang, Giao Q. Phan, Marybeth S. Hughes, Richard M. Sherry, Mark Raffeld, Steven Feldman, Lily Lu, Yong F. Li, Lien T. Ngo, Andre Goy, Tatyana Feldman, David E. Spaner, Michael L. Wang, Clara C. Chen, Sarah M. Kranick, Avindra Nath, Debbie-Ann N. Nathan, Kathleen E. Morton, Mary Ann Toomey, Steven A. Rosenberg, Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor Journal of Clinical Oncology. ,vol. 33, pp. 540- 549 ,(2015) , 10.1200/JCO.2014.56.2025

Joseph A. Fraietta, Kyle A. Beckwith, Prachi R. Patel, Marco Ruella, Zhaohui Zheng, David M. Barrett, Simon F. Lacey, Jan Joseph Melenhorst, Shannon E. McGettigan, Danielle R. Cook, Changfeng Zhang, Jun Xu, Priscilla Do, Jessica Hulitt, Sagar B. Kudchodkar, Alexandria P. Cogdill, Saar Gill, David L. Porter, Jennifer A. Woyach, Meixiao Long, Amy J. Johnson, Kami Maddocks, Natarajan Muthusamy, Bruce L. Levine, Carl H. June, John C. Byrd, Marcela V. Maus, Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia Blood. ,vol. 127, pp. 1117- 1127 ,(2016) , 10.1182/BLOOD-2015-11-679134

Cameron J. Turtle, Kevin A. Hay, Laïla-Aïcha Hanafi, Daniel Li, Sindhu Cherian, Xueyan Chen, Brent Wood, Arletta Lozanski, John C. Byrd, Shelly Heimfeld, Stanley R. Riddell, David G. Maloney, Durable Molecular Remissions in Chronic Lymphocytic Leukemia Treated With CD19-Specific Chimeric Antigen Receptor–Modified T Cells After Failure of Ibrutinib Journal of Clinical Oncology. ,vol. 35, pp. 3010- 3020 ,(2017) , 10.1200/JCO.2017.72.8519

Kerry A. Rogers, Ying Huang, Amy S. Ruppert, Galena Salem, Deborah M. Stephens, Nyla A. Heerema, Leslie A. Andritsos, Farrukh T. Awan, John C. Byrd, Joseph M. Flynn, Kami J. Maddocks, Jeffrey A. Jones, A single-institution retrospective cohort study of first-line R-EPOCH chemoimmunotherapy for Richter syndrome demonstrating complex chronic lymphocytic leukaemia karyotype as an adverse prognostic factor. British Journal of Haematology. ,vol. 180, pp. 259- 266 ,(2018) , 10.1111/BJH.15035

Irit Avivi, Januario E. Castro, Jason R. Westin, Julio C. Chavez, Armin Ghobadi, Krishna V. Komanduri, Ronald Levy, Eric D. Jacobsen, Thomas E. Witzig, Patrick Reagan, Adrian Bot, John Rossi, Lynn Navale, Yizhou Jiang, Jeff Aycock, Meg Elias, David Chang, Jeff Wiezorek, William Y. Go, Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett, Lazaros J. Lekakis, David B. Miklos, Caron A. Jacobson, Ira Braunschweig, Olalekan O. Oluwole, Tanya Siddiqi, Yi Lin, John M. Timmerman, Patrick J. Stiff, Jonathan W. Friedberg, Ian W. Flinn, Andre Goy, Brian T. Hill, Mitchell R. Smith, Abhinav Deol, Umar Farooq, Peter McSweeney, Javier Munoz, Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma The New England Journal of Medicine. ,vol. 377, pp. 2531- 2544 ,(2017) , 10.1056/NEJMOA1707447

Joseph A. Fraietta, Simon F. Lacey, Elena J. Orlando, Iulian Pruteanu-Malinici, Mercy Gohil, Stefan Lundh, Alina C. Boesteanu, Yan Wang, Roddy S. O’Connor, Wei-Ting Hwang, Edward Pequignot, David E. Ambrose, Changfeng Zhang, Nicholas Wilcox, Felipe Bedoya, Corin Dorfmeier, Fang Chen, Lifeng Tian, Harit Parakandi, Minnal Gupta, Regina M. Young, F. Brad Johnson, Irina Kulikovskaya, Li Liu, Jun Xu, Sadik H. Kassim, Megan M. Davis, Bruce L. Levine, Noelle V. Frey, Donald L. Siegel, Alexander C. Huang, E. John Wherry, Hans Bitter, Jennifer L. Brogdon, David L. Porter, Carl H. June, J. Joseph Melenhorst, Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia. Nature Medicine. ,vol. 24, pp. 563- 571 ,(2018) , 10.1038/S41591-018-0010-1

Investigators J. Schuster SJ, Bishop MR, Tam CS, Waller EK, Borchmann P, McGuirk JP, Jager U, Jaglowski S, Andreadis C, Westin JR, Fleury I, Bachanova V, Foley SR, Ho PJ, Mielke S, Magenau JM, Holte H, Pantano S, Pacaud LB, Awasthi R, Chu J, Anak O, Salles G, Maziarz RT, None, Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma The New England Journal of Medicine. ,vol. 380, pp. 45- 56 ,(2019) , 10.1056/NEJMOA1804980